Found: 98
Select item for more details and to access through your institution.
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1037, doi. 10.1002/ajh.23822
- By:
- Publication type:
- Article
Aberrant metabolic processes promote the immunosuppressive microenvironment in multiple myeloma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1077768
- By:
- Publication type:
- Article
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37699-z
- By:
- Publication type:
- Article
Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 518, doi. 10.1093/cid/ciad605
- By:
- Publication type:
- Article
Prominent immune signatures of T cells are specifically associated with indolent B‐cell lymphoproliferative disorders and predict prognosis.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 1, p. N.PAG, doi. 10.1002/cti2.1105
- By:
- Publication type:
- Article
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-023-00448-5
- By:
- Publication type:
- Article
COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 3, p. 643, doi. 10.1007/s13402-021-00590-4
- By:
- Publication type:
- Article
The Significance of Bone Marrow Involvement in Aggressive Lymphomas: A Retrospective Comparison of Clinical Outcomes between Peripheral T Cell Lymphoma and Diffuse Large B Cell Lymphoma in China.
- Published in:
- Acta Haematologica, 2010, v. 124, n. 4, p. 239, doi. 10.1159/000321544
- By:
- Publication type:
- Article
Clinical Characteristics and Treatment Outcome of Adult Acute Lymphoblastic Leukemia with t(4;11)(q21;q23) Using a Modified Hyper-CVAD Regimen.
- Published in:
- Acta Haematologica, 2009, v. 122, n. 1, p. 23, doi. 10.1159/000232579
- By:
- Publication type:
- Article
A Retrospective Analysis of Thirty-One Cases of Plasma Cell Leukemia from a Single Center in China.
- Published in:
- Acta Haematologica, 2009, v. 121, n. 1, p. 47, doi. 10.1159/000210555
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of follicular lymphoma patients with extranodal involvement: analysis of a series of 1090 cases in China.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 6, p. 1821, doi. 10.1007/s12094-023-03081-0
- By:
- Publication type:
- Article
BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.
- Published in:
- BMC Medical Genetics, 2017, v. 18, p. 1, doi. 10.1186/s12881-017-0381-z
- By:
- Publication type:
- Article
P-211: Phase 2 MARCH study: ATG-010 plus Dexamethasone in Chinese relapsed/refractory Multiple Myeloma (RRMM) patients previously treated with an immunomodulatory agent (IMiD) and a proteasome inhibitor (PI).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S155, doi. 10.1016/S2152-2650(21)02338-7
- By:
- Publication type:
- Article
P-174: Clinical study of bortezomib-based regimens of BCD, PAD and VDD for newly diagnosed multiple myeloma – an analysis of 400 cases in a single center of China.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S131, doi. 10.1016/S2152-2650(21)02301-6
- By:
- Publication type:
- Article
P-088: Indirubin-3'-monoxime acts as an alternative proteasome inhibitor and confers new regimens for the treatment of Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S87, doi. 10.1016/S2152-2650(21)02222-9
- By:
- Publication type:
- Article
P-081: A novel circulating miRNA involved in T cell senescence of multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S83, doi. 10.1016/S2152-2650(21)02215-1
- By:
- Publication type:
- Article
OAB-039: Distinct immunoglobulin heavy-chain variable gene repertoire and its clinical relevance in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S25, doi. 10.1016/S2152-2650(21)02113-3
- By:
- Publication type:
- Article
OAB-021: BCMA-specific ADC MEDI2228 and Daratumumab induce synergistic myeloma cytotoxicity via enhanced IFN-driven innate immune responses and expression of CD38 and NKG2D ligands.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S13, doi. 10.1016/S2152-2650(21)02095-4
- By:
- Publication type:
- Article
OAB-011: Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single cell level.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S7, doi. 10.1016/S2152-2650(21)02085-1
- By:
- Publication type:
- Article
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Subtype Distribution, Clinical Features, and Survival in B-cell Chronic Lymphoproliferative Disorders in China: A Review of 1592 Cases.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
- By:
- Publication type:
- Article
Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e229, doi. 10.1016/j.clml.2019.09.380
- By:
- Publication type:
- Article
Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.369
- By:
- Publication type:
- Article
The prognostic impact of dynamic changing of cytogenetic abnormalities under the treatment options in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e221, doi. 10.1016/j.clml.2019.09.368
- By:
- Publication type:
- Article
The impact of response kinetics following initial therapy for multiple myeloma in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.370
- By:
- Publication type:
- Article
DNp73 promotes the proliferation and drug resistance of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e140, doi. 10.1016/j.clml.2019.09.234
- By:
- Publication type:
- Article
YWHAE/14-3-3ε expression impacts the proteasome load contributing to proteasome inhibitor sensitivity in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e111, doi. 10.1016/j.clml.2019.09.184
- By:
- Publication type:
- Article
The bone marrow microenvironment of multiple myeloma promotes myeloma related anemia by suppressing the differentiation of hematopoietic stem cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e92, doi. 10.1016/j.clml.2019.09.150
- By:
- Publication type:
- Article
Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e83, doi. 10.1016/j.clml.2019.09.132
- By:
- Publication type:
- Article
IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e82, doi. 10.1016/j.clml.2019.09.131
- By:
- Publication type:
- Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
- By:
- Publication type:
- Article
APOBEC3B is induced by activation of DNA damage pathway and regulates the survival and treatment response in human multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e51, doi. 10.1016/j.clml.2019.09.078
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Ibrutinib Efficacy, Safety, and Pharmacokinetics in Chinese Patients with Relapsed or Refractory Waldenström's Macroglobulinemia: A Multicenter, Single-Arm, Phase 4 Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 2, p. 672, doi. 10.1007/s12325-023-02720-w
- By:
- Publication type:
- Article
Zanubrutinib Monotherapy for Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study: Treatment pattern and outcomes in patients with multiple myeloma.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 1, p. 640, doi. 10.1007/s12325-020-01546-0
- By:
- Publication type:
- Article
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple Myeloma.
- Published in:
- Advanced Science, 2022, v. 9, n. 9, p. 1, doi. 10.1002/advs.202104491
- By:
- Publication type:
- Article
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00378-z
- By:
- Publication type:
- Article
Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 1, p. 1, doi. 10.1002/ctm2.1140
- By:
- Publication type:
- Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Targeting stem cell niche can protect hematopoietic stem cells from chemotherapy and G-CSF treatment.
- Published in:
- Stem Cell Research & Therapy, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s13287-015-0164-4
- By:
- Publication type:
- Article
Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma.
- Published in:
- Molecular Oncology, 2020, v. 14, n. 4, p. 763, doi. 10.1002/1878-0261.12641
- By:
- Publication type:
- Article
Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria.
- Published in:
- Microbiome, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40168-020-00854-5
- By:
- Publication type:
- Article
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 4, p. 1043, doi. 10.1002/cam4.1337
- By:
- Publication type:
- Article
Targeting p53 via JNK Pathway: A Novel Role of RITA for Apoptotic Signaling in Multiple Myeloma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0030215
- By:
- Publication type:
- Article
Treatment and Prognosis of Adult T Cell Acute Lymphoblastic Leukemia.
- Published in:
- Acta Academiae Medicinae Sinica, 2019, v. 41, n. 4, p. 485, doi. 10.3881/j.issn.1000-503X.10807
- By:
- Publication type:
- Article